NCT02995239

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

A Randomized, Open-label, Single Dose, Crossover Study to Compare the Pharmacokinetic Characteristics of CJ-12420 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: HK inno.N Corporation · Industry
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

To compare the pharmacokinetics after administration of different formulation of CJ-12420

Detailed description

The purpose of this study is to compare the pharmacokinetics after a single dose administration of CJ-12420 formulation 1 and formulation 2.

Conditions

• Erosive Esophagitis

Interventions

Type	Name	Description
DRUG	CJ-12420 formulation 2	CJ-12420 formulation 2
DRUG	CJ-12420 formulation 1	CJ-12420 formulation 1

Timeline

• Start date: 2015-04-01
• Primary completion: 2015-04-01
• Completion: 2015-04-01
• First posted: 2016-12-16
• Last updated: 2016-12-16

Locations

1 site across 1 country: South Korea